Scolaris Content Display Scolaris Content Display

Cochrane Database of Systematic Reviews

Immunomodulators and immunosuppressants for relapsing‐remitting multiple sclerosis: a network meta‐analysis

Esta versión no es la más reciente

ver la versión actual 04 enero 2024

Información

DOI:
https://doi.org/10.1002/14651858.CD011381Copiar DOI
Base de datos:
  1. Cochrane Database of Systematic Reviews
Versión publicada:
  1. 13 noviembre 2014see what's new
Tipo:
  1. Intervention
Etapa:
  1. Protocol
Grupo Editorial Cochrane:

  1. Grupo Cochrane de Esclerosis múltiple y enfermedades raras del sistema nervioso central

Copyright:
  1. Copyright © 2014 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.

Cifras del artículo

Altmetric:

Citado por:

Citado 0 veces por enlace Crossref Cited-by

Contraer

Autores

  • Irene Tramacere

    Neuroepidemiology Unit, Fondazione I.R.C.C.S. Istituto Neurologico Carlo Besta, Milano, Italy

  • Cinzia Del Giovane

    Italian Cochrane Centre, Department of Diagnostic, Clinical and Public Health Medicine, University of Modena and Reggio Emilia, Modena, Italy

  • Georgia Salanti

    Department of Hygiene and Epidemiology, University of Ioannina School of Medicine, Ioannina, Greece

  • Roberto D'Amico

    Italian Cochrane Centre, Department of Diagnostic, Clinical and Public Health Medicine, University of Modena and Reggio Emilia, Modena, Italy

  • Ilaria Pacchetti

    Neuroepidemiology Unit, Fondazione I.R.C.C.S. Istituto Neurologico Carlo Besta, Milano, Italy

  • Graziella Filippini

    Correspondencia a: Scientific Direction, Fondazione I.R.C.C.S. Istituto Neurologico Carlo Besta, Milano, Italy

    [email protected]

Contributions of authors

Concept‐ GF, GS

Title registration‐ GF

Protocol Draft‐ GF, IT, CDG, GS

Protocol editing‐ GF, IT, CDG, GS, RD

Sources of support

Internal sources

  • Fondazione Istituto Neurologico Carlo Besta ‐ Milan, Italy.

External sources

  • Ministero della Salute, Italy.

Declarations of interest

GF ‐ none

GS ‐ none

CDG ‐ none

IT ‐ none

RD ‐ none

IP ‐ none

Acknowledgements

We thank Andrea Fittipaldo for developing search strategy methods for identification of studies.

Version history

Published

Title

Stage

Authors

Version

2024 Jan 04

Immunomodulators and immunosuppressants for relapsing‐remitting multiple sclerosis: a network meta‐analysis

Review

Marien Gonzalez-Lorenzo, Ben Ridley, Silvia Minozzi, Cinzia Del Giovane, Guy Peryer, Thomas Piggott, Matteo Foschi, Graziella Filippini, Irene Tramacere, Elisa Baldin, Francesco Nonino

https://doi.org/10.1002/14651858.CD011381.pub3

2015 Sep 18

Immunomodulators and immunosuppressants for relapsing‐remitting multiple sclerosis: a network meta‐analysis

Review

Irene Tramacere, Cinzia Del Giovane, Georgia Salanti, Roberto D'Amico, Graziella Filippini

https://doi.org/10.1002/14651858.CD011381.pub2

2014 Nov 13

Immunomodulators and immunosuppressants for relapsing‐remitting multiple sclerosis: a network meta‐analysis

Protocol

Irene Tramacere, Cinzia Del Giovane, Georgia Salanti, Roberto D'Amico, Ilaria Pacchetti, Graziella Filippini

https://doi.org/10.1002/14651858.CD011381

Keywords

MeSH

Medical Subject Headings (MeSH) Keywords

Medical Subject Headings Check Words

Adult; Humans;

PICO

Population
Intervention
Comparison
Outcome

El uso y la enseñanza del modelo PICO están muy extendidos en el ámbito de la atención sanitaria basada en la evidencia para formular preguntas y estrategias de búsqueda y para caracterizar estudios o metanálisis clínicos. PICO son las siglas en inglés de cuatro posibles componentes de una pregunta de investigación: paciente, población o problema; intervención; comparación; desenlace (outcome).

Para saber más sobre el uso del modelo PICO, puede consultar el Manual Cochrane.

Network of all possible pairwise comparisons of treatments and placebo. The placebo node is white as it is expected without any activity. Interferons include interferon beta‐1a (Avonex and Rebif) and interferon beta‐1b.
Figuras y tablas -
Figure 1

Network of all possible pairwise comparisons of treatments and placebo. The placebo node is white as it is expected without any activity. Interferons include interferon beta‐1a (Avonex and Rebif) and interferon beta‐1b.

Ir a la figura del protocoloAbrir en una pestaña nueva